List of Navidea Biopharmaceuticals, Inc. patents

List of Navidea Biopharmaceuticals, Inc. patents

List of Scancell patents

List of Cellectis patents

List of Novocure patents

List of NGOs in Japan

Nuclear energy venture capital investors

Patents where

Current Assignee

Name

is

Navidea Biopharmaceuticals, Inc.

	Name	Description	Patent Applicant	Current Assignee	Inventor	Patent Jurisdiction	Patent Number	Date of Patent
	‌ US Patent 8227766 Hand-held probe for intra-operative detection of fluorescence labeled compounds and antibodies	Patent 8227766 was granted and assigned to Navidea Biopharmaceuticals, Inc. on July, 2012 by the United States Patent and Trademark Office.		Navidea Biopharmaceuticals, Inc.		United States Patent and Trademark Office	8227766	July 24, 2012
	‌ US Patent 11369680 Compounds and compositions for treating leishmaniasis and methods of diagnosis and treating using same	Patent 11369680 was granted and assigned to Navidea Biopharmaceuticals, Inc. on June, 2022 by the United States Patent and Trademark Office.	Navidea Biopharmaceuticals, Inc.	Navidea Biopharmaceuticals, Inc.		United States Patent and Trademark Office	11369680	June 28, 2022
	‌ US Patent 11007272 Compounds and methods for diagnosis and treatment of viral infections	Patent 11007272 was granted and assigned to Navidea Biopharmaceuticals, Inc. on May, 2021 by the United States Patent and Trademark Office.	Navidea Biopharmaceuticals, Inc.	Navidea Biopharmaceuticals, Inc.		United States Patent and Trademark Office	11007272	May 18, 2021
	‌ US Patent 9439985 Compositions for radiolabeling diethylenetriaminepentaacetic acid (DTPA)-dextran	Patent 9439985 was granted and assigned to Navidea Biopharmaceuticals, Inc. on September, 2016 by the United States Patent and Trademark Office.	Navidea Biopharmaceuticals, Inc.	Navidea Biopharmaceuticals, Inc.		United States Patent and Trademark Office	9439985	September 13, 2016
	‌ US Patent 8957215 Heteroaryl substituted benzothiazoles	Patent 8957215 was granted and assigned to Navidea Biopharmaceuticals, Inc. on February, 2015 by the United States Patent and Trademark Office.		Navidea Biopharmaceuticals, Inc.		United States Patent and Trademark Office	8957215	February 17, 2015
	‌ US Patent 8545808 Compositions for radiolabeling diethylenetriaminepentaacetic acid (DTPA)-dextran			Navidea Biopharmaceuticals, Inc.		United States Patent and Trademark Office	8545808	October 1, 2013
	‌ US Patent 11590236 Compositions and methods for altering macrophage phenotype		Navidea Biopharmaceuticals, Inc.	Navidea Biopharmaceuticals, Inc.		United States Patent and Trademark Office	11590236	February 28, 2023
	‌ US Patent 12005122 Compounds and methods for diagnosis and treatment of viral infections	Patent 12005122 was granted and assigned to Navidea Biopharmaceuticals, Inc. on June, 2024 by the United States Patent and Trademark Office.	Navidea Biopharmaceuticals, Inc.	Navidea Biopharmaceuticals, Inc.		United States Patent and Trademark Office	12005122	June 11, 2024
	‌ US Patent 12006339 CD206 targeted drug delivery vehicles carrying novel bisphosphonate drug payloads via a degradable linker	Patent 12006339 was granted and assigned to Navidea Biopharmaceuticals, Inc. on June, 2024 by the United States Patent and Trademark Office.	Navidea Biopharmaceuticals, Inc.	Navidea Biopharmaceuticals, Inc.		United States Patent and Trademark Office	12006339	June 11, 2024
	‌ US Patent 11859023 Synthesis of uniformly defined molecular weight mannosylated dextrans and derivatives thereof	Patent 11859023 was granted and assigned to Navidea Biopharmaceuticals, Inc. on January, 2024 by the United States Patent and Trademark Office.	Navidea Biopharmaceuticals, Inc.	Navidea Biopharmaceuticals, Inc.		United States Patent and Trademark Office	11859023	January 2, 2024
	‌ US Patent 11833170 Altering net charge on mannosylated dextrans to maximize target tissue uptake and off target competitive blocking	Patent 11833170 was granted and assigned to Navidea Biopharmaceuticals, Inc. on December, 2023 by the United States Patent and Trademark Office.	Navidea Biopharmaceuticals, Inc.	Navidea Biopharmaceuticals, Inc.		United States Patent and Trademark Office	11833170	December 5, 2023

11 results

0 selected

11 results

0 selected